Articles Tagged With: Contraception
-
Does Postpartum Use of Hormonal Contraception Increase Risk of Depression?
An analysis of a large insurance database showed no consistent effect between postpartum initiation of hormonal contraception and the subsequent diagnosis of depression.
-
Time to Update Your Knowledge of Long-Acting Reversible Contraceptives
Practice bulletin says intrauterine, implant options are safe and effective for almost all women.
-
Vending Machines Expand Options for College Health Emergency Contraception
While age restrictions on levonorgestrel emergency contraceptive pills (ECPs) were removed in 2013, access to pills often is tricky, even for college-age students. Now Stanford University and University of California locations in Santa Barbara and Davis are among the latest campuses that have installed vending machines stocked with ECPs.
-
The LNG IUS and Stress Reactivity: A Mechanism for Mood Effects or False Signal?
Users of the levonorgestrel (LNG) intrauterine system showed an exaggerated response to stress compared to women using a combined LNG pill or those with natural cycles.
-
Postpartum Placement of Hormonal IUD Does Not Affect Breastfeeding Outcomes
Women can avoid unintended pregnancy and successfully breastfeed.
-
Vasectomy Poses Minimal Prostate Cancer Risk
A new systematic review and meta-analysis of three decades of evidence concludes that vasectomies are associated with minimal risk of prostate cancer.
-
Research Finds Many Women Who Receive IUD for Emergency Contraception Continue Use
Sixty-seven percent of women offered long-acting option were using it at one year.
-
Reproductive Rights in 2017: Follow-up and Call for Advocacy
The Trump administration has made good on a number of promises to roll back reproductive rights. As clinicians, we need to fight back to ensure access for our patients to essential services. This article seeks to document where we stand as of summer 2017, and present opportunities for engagement.
-
While Many Pharmacies Have EC, Can Teens Access It?
In 2013, the Food and Drug Administration removed age restrictions on emergency contraception (EC), allowing it to be sold over the counter to all consumers. However, results of a new study indicate that barriers to and disparities in access for adolescents still exist.
-
Data Indicate Efficacy of Liletta IUD for Four Years’ Use
Four-year data from the ongoing multicenter, U.S.-based pivotal trial of the 52 mg Liletta levonorgestrel-releasing intrauterine device (IUD) indicate its safety and efficacy for four years of use in nulliparous and parous women, as well as in non-obese and obese women.